Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Antimicrobial Resistance Surveillance Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_
The antimicrobial resistance surveillance market has experienced significant expansion in recent years. It is anticipated to increase from $7.3 billion in 2025 to $7.91 billion in 2026, at a compound annual growth rate (CAGR) of 8.4%. This historical growth can be attributed to a rise in drug-resistant infections, hospital infection control initiatives, public health surveillance programs, laboratory testing expansion, and antibiotic misuse concerns._x000D_
_x000D_
The antimicrobial resistance surveillance market is anticipated to experience substantial expansion over the coming years, with its value projected to reach $10.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This projected increase throughout the forecast period stems from factors such as global initiatives for AMR monitoring, AI-powered predictive surveillance, the adoption of cloud-based data sharing, the expansion of genomic surveillance, and policy-mandated reporting requirements. Key developments anticipated during this period include real-time monitoring of resistance patterns, the implementation of whole genome sequencing for surveillance, AI-driven resistance analytics, the integration of public health databases, and the establishment of hospital-wide AMR tracking systems._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Antimicrobial Resistance Surveillance Market Demand Drivers Opening New Revenue Streams#_x000D_
The antimicrobial resistance surveillance market is anticipated to expand due to the growing occurrence of infectious diseases. These conditions are triggered by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals through direct or indirect contact. The escalating incidence of infectious diseases stems from factors including climate change, urbanization, and international travel, all of which facilitate the dissemination of pathogens and increase human contact with novel microbes. Tracking the distribution of resistant pathogens is aided by antimicrobial resistance surveillance, which in turn helps formulate effective treatment approaches and shapes public health initiatives aimed at combating infectious diseases. As an illustration, a report released by the UK Health Security Agency, a UK-based government agency, in February 2024, revealed that tuberculosis (TB) cases in England rose by 10.7% in 2023, totaling 4,850 cases, up from 4,380 in 2022. Consequently, the expanding occurrence of infectious diseases is a key factor boosting the antimicrobial resistance surveillance market._x000D_
_x000D_
#Antimicrobial Resistance Surveillance Market Segment Landscape And Growth Outlook#_x000D_
The antimicrobial resistance surveillance market covered in this report is segmented – _x000D_
_x000D_
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services_x000D_
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications_x000D_
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits _x000D_
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems _x000D_
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems _x000D_
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services_x000D_
_x000D_
#Antimicrobial Resistance Surveillance Market Trends Powering Strategic Industry Growth#_x000D_
Key companies operating in the market are concentrating on advanced technologies, such as innovative diagnostic instruments, to streamline operations, enhance efficiency, improve accuracy, reduce costs, and achieve superior outcomes for patients and end-users. A diagnostic tool is defined as any device, instrument, software, or methodology used to identify, detect, or assess the presence of a condition, disease, malfunction, or issue. For example, in June 2023, Sysmex Astrego AB, a Sweden-based producer and provider of diagnostic products and services, announced the introduction of its PA-100 AST Point-of-Care Testing System. This system facilitates quick and precise detection of antimicrobial resistance at the point of care, offering a notable time reduction compared to conventional laboratory methods, which can take up to several days. By delivering results in just 30 minutes, it enables clinicians to make timely and informed decisions about appropriate infection treatments, thereby lessening the reliance on broad-spectrum antibiotics and assisting in the battle against the spread of antimicrobial resistance._x000D_
_x000D_
#Antimicrobial Resistance Surveillance Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio‑Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l. _x000D_
_x000D_
#View The Full Antimicrobial Resistance Surveillance Market Report:#_x000D_
_x000D_
#Antimicrobial Resistance Surveillance Market Geographic Distribution And Regional Opportunities#_x000D_
North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
